Intravenous methylprednisolone for multiple sclerosis in relapse.
about
Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case seriesNano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative DiseasesQuantitative magnetic resonance imaging in multiple sclerosis: the effect of high dose intravenous methylprednisolone.High-performance liquid-chromatographic-atmospheric-pressure chemical-ionization ion-trap mass-spectrometric identification of isomeric C6-hydroxy and C20-hydroxy metabolites of methylprednisolone in the urine of patients receiving high-dose pulse tHigh dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effectMethylprednisolone therapy in multiple sclerosis: a profile of adverse effects.A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effectsDouble blind placebo controlled multicentre study of ginkgolide B in treatment of acute exacerbations of multiple sclerosis. The Ginkgolide Study Group in multiple sclerosis.Current pharmacologic treatment of multiple sclerosis symptoms.Multiple sclerosis: diagnosis and the management of acute relapsesManagement of patients who have relapses in multiple sclerosis.Treatment of acute relapses in multiple sclerosis.Immunotherapy for multiple sclerosis.Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.Assessing relapses and response to relapse treatment in patients with multiple sclerosis: a nursing perspective.Immunotherapy of multiple sclerosis: the state of the art.Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.Investigational drug therapies of treatment of multiple sclerosis.Current immunotherapy in multiple sclerosis.Methylprednisolone in multiple sclerosis: a comparative dose studyUse of adrenocorticosteroid hormones in the treatment of multiple sclerosis.
P2860
Q26748598-EFB3B487-785A-4FF4-A74B-59B50CEC4948Q28546214-8A6BDA56-59E5-44BE-8A5D-432642E7CD94Q31080169-1D2933CF-B5C1-4F28-814F-2663DE53615CQ33421296-A0D0E88D-A900-486D-BD68-C9AACB8384C2Q33590797-D62EA108-ED6B-4980-96CC-514872855513Q33627373-7FA96BAB-7BA9-4954-9282-33579F844A6FQ33628316-C9210847-7E2D-42FF-AE57-4F0AF36B1369Q33733870-2D47C676-AC43-4834-BA13-DE6F837ACFF1Q34184505-9FB930F9-EBED-4F80-9782-D4E21D62A3C3Q35521828-78D3A8A7-1E6C-4721-B955-53B41187E74EQ35953086-9907BB1A-12CB-4E1C-8BCA-CA75DBDC095EQ36568671-45003672-5978-4E70-AE66-293B1A051AE7Q36850073-292908D4-F827-440E-AD13-82BAFC3BE7ECQ36981808-849D9A42-9F3E-485F-AB2D-CF26E4CCE323Q37442240-C7873A62-6C4B-40A0-9287-2E81F2C2E46DQ38083041-42D29374-90D3-40D3-8272-553BEF83920FQ40641045-9CD84B63-C328-4756-AF1D-EE4987A31700Q41622019-3133F299-4939-4E1C-9C88-CB876CE82A9AQ41745131-EC1CD7AA-8F60-4253-968C-E106C634BA8CQ42589723-DDD990EF-60F5-4F0A-AE69-FF12E9D97DF8Q48457492-82F222EF-BB65-41B6-A5A5-C23117CCD7DE
P2860
Intravenous methylprednisolone for multiple sclerosis in relapse.
description
1985 nî lūn-bûn
@nan
1985 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Intravenous methylprednisolone for multiple sclerosis in relapse.
@ast
Intravenous methylprednisolone for multiple sclerosis in relapse.
@en
type
label
Intravenous methylprednisolone for multiple sclerosis in relapse.
@ast
Intravenous methylprednisolone for multiple sclerosis in relapse.
@en
prefLabel
Intravenous methylprednisolone for multiple sclerosis in relapse.
@ast
Intravenous methylprednisolone for multiple sclerosis in relapse.
@en
P2093
P356
P1476
Intravenous methylprednisolone for multiple sclerosis in relapse.
@en
P2093
Bateman DE
Cleland PG
Saunders M
P2860
P304
P356
10.1136/JNNP.48.2.157
P407
P577
1985-02-01T00:00:00Z